The growing issue of novel psychoactive substances (NPS), often dubbed "designer drugs," presents a significant problem to global public health and law enforcement. These compounds, frequently synthesized to circumvent existing drug laws, quickly appear on the scene and are marketed as "legal highs" or "research chemicals," attracting individuals,